Value Bridge — ALBERT EINSTEIN MEDICAL CENTER
Current $-43M → Target $-24M (+$19.0M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-43.1M
Current EBITDA
$-24.0M
Target EBITDA
+$19.0M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$4.3M
Payer Mix Optimization
$10.3M
Cost to Collect Reduction
$3.4M
Clean Claim Improvement
$2.6M
Volume & Rate Growth
$17.2M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-43M to $-24M. The highest-impact lever is Volume & Rate Growth at $6.9M probability-weighted.
IC talking point: "We see $19M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $209M in equity value creation."